Skip to content

Rehabilitation effect of Yunnan Baiyao on postoperative brain Protection in traumatic brain injury patients

Rehabilitation effect of Yunnan Baiyao on postoperative brain Protection in traumatic brain injury patients-A randomized placebo-controlled study based on standard treatmen

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030280
Enrollment
Unknown
Registered
2020-02-27
Start date
2019-09-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury

Interventions

Sponsors

Department of Neurosurgery, The first medical center of the Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Acute TBI patients admitted within 8 hours of injury were enrolled in the study. They were diagnosed with acute moderate to severe TBI(Glasgow Coma Scale score on admission was 3 to 12)and without other important organs were injured .Intracranial brain contusion and laceration confirmed by head Computed tomography (CT)hematoma intracranial hematoma epidural or subdural hematoma and other clear organic lesions. Patients were included if they were between15 and 65 years of age, required emergency craniotomy and were operated on within 12 hours of injury.

Exclusion criteria

Exclusion criteria: The exclusion criteria included severe multiple or combined injury patients, history of severe chronic illness,Participants in any other drug trial 1 month prior to the trial and during the trial period,had malignant tumor and other diseases of the nervous system and immune system,pregnant and lactating women,patients with blood transfusion of more than 400ml during treatment,Uncooperative, automatic discharge or death patients, patients who need a second craniotomy due to changes in their condition and any history of allergy to YNBY capsules.

Design outcomes

Primary

MeasureTime frame
Glasgow Coma Scale, GCS;Glasgow Outcome Scale, GOS;Karnofsky Performance Scale, KPS;S100B;Superoxide Dismutase SOD;

Countries

China

Contacts

Public ContactXiao-dong Ma

Department of Neurosurgery, The first medical center of the Chinese PLA General Hospital

xiaodongm@hotmail.com+86 13911764523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026